| Adverse effect |
Odds ratio; 95% CI; heterogeneity; N of studies, N of participants |
P value |
| Head, eyes, ears, nose, and throat |
OR 0.17, 95% CI 0.02 to 1.67; 1 study, 30 participants |
P = 0.13 |
| Gastrointestinal |
OR 1.20, 95% CI 0.24 to 6.06; 1 study, 30 participants |
P = 0.83 |
| Genito‐urinary |
OR 1.15, 95% CI 0.07 to 20.34; 1 study, 30 participants |
P = 0.92 |
| Musculo/skeletal |
OR 1.15, 95% CI 0.07 to 20.34; 1 study, 30 participants |
P = 0.92 |
| Pulmonary |
OR 1.17, 95% CI 0.14 to 9.59; 1 study, 30 participants |
P = 0.89 |
| Psychiatric |
OR 0.51, 95% CI 0.11 to 2.36; 1 study, 30 participants |
P = 0.39 |
